First-line vascular endothelial growth factor targeted therapy in renal cell carcinoma: priming the tumor microenvironment for immunotherapy-Reference-Cited by-同舟云学术

First-line vascular endothelial growth factor targeted therapy in renal cell carcinoma: priming the tumor microenvironment for immunotherapy

Published:2018-02-01 Issue:5 Volume:34 Page:825-831
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Tannir Nizar¹,Hammers Hans²,Amin Asim³

Affiliation:

1. Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

2. UT Southwestern, Simmons Comprehensive Cancer Center, Kidney Cancer Program, Dallas, TX, USA;

3. Division of Immunotherapy, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA

Funder

Novartis Oncology, Novartis Pharmaceuticals Corporation

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1423960

Reference50 articles.

1. American Cancer Society. Kidney Cancer. 2016. Available at: https://www.cancer.org/cancer/kidney-cancer.html [Last accessed 10 October 2017]

2. Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene

3. Renal cell carcinoma

4. National Comprehensive Cancer Network. NCCN Clinical Practice Guidlines in Oncology. Kidney Cancer, version 1. 2018. 2017. Available at: https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf [Last accessed 10 October 2017]

5. The Right Drug for the Right Patient: Navigating Systemic Therapy Options in Metastatic Renal Cell Carcinoma and Future Directions

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma;Heliyon;2024-04

2. Therapeutic Potential of Natural Products in the Treatment of Renal Cell Carcinoma: A Review;Nutrients;2022-05-28

3. Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer;Frontiers in Immunology;2022-05-23

4. Hybrid Therapy (Surgery and Radiosurgery) for the Treatment of Renal Cell Carcinoma Spinal Metastases;Neurosurgery;2021-12-13

5. Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?;Cancers;2021-10-10